LIQUIDIA CORPORATION Business Combination, Indemnification Assets, Amount as of Acquisition Date
LIQUIDIA CORPORATION (LQDA) had Business Combination, Indemnification Assets, Amount as of Acquisition Date of $1.39 million as of 2020-12-31, per its 10-K filed 2021-03-25.
Discontinued › Notes
us-gaap:BusinessCombinationIndemnificationAssetsAmountAsOfAcquisitionDate · last filed 2021-03-25
- 2020-12-31: Business Combination, Indemnification Assets, Amount as of Acquisition Date $1.39M.
- 2019-12-31: Business Combination, Indemnification Assets, Amount as of Acquisition Date $0.00.
| Period end | Business Combination, Indemnification Assets, Amount as of Acquisition Date |
|---|---|
| 2020-12-31 | $1.39M 10-K · filed 2021-03-25 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |